Caidya®

Navigating Complexities: How Caidya Enabled Success in a Global Phase 3 AML Study

Phase 3 AML Clinical Trial

Discover how Caidya delivered results in a global Phase 3 AML clinical trial through proactive planning, site activation, and data coordination across 18 countries.

Read the Case Study

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

News

03/13/2025

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology

RALEIGH, N.C.; Mar. 13, 2025 – Caidya, a leading global,...
Read more

News

01/28/2025

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025 – Caidya, a leading global,...
Read more

News

01/13/2025

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global...
Read more
Skip to toolbar